Arenicin-1

General Information


DRACP ID  DRACP00187

Peptide Name   Arenicin-1

Sequence  RWCVYAYVRVRGVLVRYRRCW

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Arenicola marina

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
Jurkat Childhood T acute lymphoblastic leukemia; Precursor T-cell acute lymphoblastic leukemia Leukemia LD50=4 µM Alamar blue assay 30 min 1
K562 Blast phase chronic myelogenous leukemia, BCR-ABL11 positive; Chronic myeloid leukemia Leukemia IC50=17.9 µM MTT assay 24h 2

Hemolytic Activity  Human erythrocytes: 0% Hemolysis=12.5 µM; 12% Hemolysis=25 µM; 35% Hemolysis=50 µM; 51% Hemolysis=100 µM; 10% Hemolysis=4.1 µM; 15% Hemolysis=10.3 µM; 50% Hemolysis=66.3 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00187

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Cys3<--->Cys20

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C127H195N41O25S2

Absent amino acids  DEFHIKMNPQST

Common amino acids  R

Mass  311723

Pl  11.15

Basic residues  6

Acidic residues  0

Hydrophobic residues  9

Net charge  6

Boman Index  -5485

Hydrophobicity  -7.14

Aliphatic Index  92.38

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  15595

Absorbance 280nm  779.75

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 17935487

Title  Structure and mode of action of the antimicrobial peptide arenicin

Doi 10.1042/BJ20071051

Year  2008

Literature 2

Pubmed ID 31234579

Title  Redesigning Arenicin-1, an Antimicrobial Peptide from the Marine Polychaeta Arenicola marina, by Strand Rearrangement or Branching, Substitution of Specific Residues, and Backbone Linearization or Cyclization

Doi 10.3390/md17060376

Year  2019

Literature 3

Pubmed ID 21241661

Title  The characteristic region of arenicin-1 involved with a bacterial membrane targeting mechanism

Doi 10.1016/j.bbrc.2011.01.046

Year  2011

Literature 4

Pubmed ID 25557880

Title  Design of antimicrobial peptide arenicin analogs with improved therapeutic indices

Doi 10.1002/psc.2732

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.